Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Antengene, Aprea, Ars, Astellas, Astrazeneca, Cassava, Chiesi, Recordati, Exelixis, Fibrogen, Innovation, Iterum, Kadmon, Mirum, Otonomy, Prevail, Protalix, Regeneron, Rhythm, Sedana, Takeda, Vertex, Y-mabs, Zymeworks.